MarketCapTrends
LLY
Eli Lilly and Company (LLY)
NYSE · Healthcare

Eli Lilly and Company Shareholder Equity 2007–2025

Eli Lilly and Company annual/quarterly shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Eli Lilly and Company shareholder equity for the quarter ending December 31, 2025 were 26.54B, a 85.92% increase year-over-year.
  • Eli Lilly and Company shareholder equity for 2025 were 26.54B, a 85.92% increase from 2024.
  • Eli Lilly and Company shareholder equity for 2024 were 14.27B, a 32.49% increase from 2023.
  • Eli Lilly and Company shareholder equity for 2023 were 10.77B, a 1.15% increase from 2022.
  • Eli Lilly and Company shareholder equity for 2022 were 10.65B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Eli Lilly and Company Annual Shareholder Equity (Millions of US $)
2025$26,535
2024$14,272
2023$10,772
2022$10,650
2021$8,979
2020$5,642
2019$2,607
2018$9,829
2017$11,592
2016$14,008
2015$14,571
2014$15,373
2013$17,631
2012$14,765
2011$13,542
Eli Lilly and Company Quarterly Shareholder Equity (Millions of US $)
2025-12-31$26,535
2024-12-31$14,272
2023-12-31$10,772
2022-12-31$10,650
2021-12-31$8,979
2020-12-31$5,642
2019-12-31$2,607
2018-12-31$9,829
2017-12-31$11,592
2016-12-31$14,008
2015-12-31$14,571
2014-12-31$15,373
2013-12-31$17,631
2012-12-31$14,765
2011-12-31$13,542
2010-12-31$12,420
2009-12-31$9,525
2008-12-31$6,738

Eli Lilly and Company Shareholder Equity — FAQ

Eli Lilly and Company (LLY) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LLY's shareholder equity history?

The chart and table above show Eli Lilly and Company's shareholder equity by year and by quarter, including the growth rate.